ClinicalTrials.Veeva

Menu

Clinical Characteristics and Outcomes Among STEMI Patients with Cardiogenic Shock At Abu Dhabi City

A

Abu Dhabi Health Services Company

Status

Enrolling

Conditions

ST Elevation Myocardial Infarction
Cardiogenic Shock

Study type

Observational

Funder types

Other

Identifiers

NCT06535503
SEHAResearch ID 747

Details and patient eligibility

About

A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.

Full description

Cardiovascular disease (CVD) accounts for 40% of mortality in the UAE, which is higher than the global average. Long-term trends, incidence studies, and best practice guidance on Cardiogenic Shock (CS) with ST-elevation Myocardial infarction (STEMI) in the United Arab Emirates (UAE) and the Gulf Cooperation Council (GCC) are limited.

Through this retrospective study, investigators aim to identify treatment modalities and trends, hospitalization events, and patient demographics and comorbidities which lead to participant recovery or mortality in Sheikh Khalifa Medical City (SKMC) and Sheikh Shakhbout Medical City (SSMC) tertiary hospitals for patients admitted with STEMI and CS or developed CS after hospitalization with STEMI during January 2020-January 2024.[200-400 participants]. Data will be collected from eligible patients' electronic medical records (EMR).

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age more than 18.
  • STEMI complicated by cardiogenic shock.
  • Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock.
  • Patient admitted between January 2019 to March 2024.

Exclusion criteria

  • Age less than 18.
  • Shock patient not related to Myocardial infarction.
  • NSTEMI-related cardiogenic shock.
  • Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock.
  • Patient not admitted between January 2019 to March 2024.

Trial design

400 participants in 1 patient group

Patients with STEMI & Cardiogenic Shock
Description:
Patients with STEMI complicated by cardiogenic shock on admission or after hospitalization treated at SKMC \& SSMC, Abu Dhbai

Trial contacts and locations

2

Loading...

Central trial contact

Alina Naeem, MBBS; Babiker Babiker Mohamed Babiker Elsiraj MB Elsiraj, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems